tgAAC94 placebo

GENETIC2 trials

Sponsors

Targeted Genetics Corporation

Conditions

Ankylosing SpondylitisArthritis, PsoriaticArthritis, RheumatoidRheumatoid Arthritis

Phase 1

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

CompletedNCT00126724

Targeted Genetics CorporationAnkylosing Spondylitis, Arthritis, Psoriatic, Arthritis, Rheumatoid

Start: 2005-08-31End: 2009-05-31Target: 120Updated: 2009-07-29

Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94

CompletedNCT00617032

Targeted Genetics CorporationRheumatoid Arthritis

Start: 2004-02-29End: 2005-11-30Updated: 2008-02-15

Related Papers

Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examination.

2010-03-158 citations

Investigation of the cause of death in a gene-therapy trial.

2009-07-0152 citations